BioSpace News Archive

FSD Pharma Inc. announced today that the Company has traded over four Billion Class B subordinate voting shares in its first six months of trading on the Canadian Securities Exchange (“CSE”).

George Clinical has continued its involvement and collaboration with the Heart Health Research Center (HHRC), further developing the depth and quality of investigator networks.

Phase 2 trial successfully reached predetermined response criteria in difficult to treat over 60, unfit patient population and demonstrated minimal extramedullary toxicities

LifeMax Laboratories, Inc. (“LifeMax”), a private company focused on treating diseases with few or no therapeutic options, today announced the appointment of Kirk Johnson, Ph.D., to the position of VP, Preclinical Development.

Revive Solutions, Inc. (“Revive” or the “Company”), a leading developer of a next generation Automated External Defibrillator (“AED”) addressing the global public health issue of Sudden Cardiac Arrest (“SCA”), has announced the completion of its $3.4M Seed Financing Round,

Dr. McMahon presents “Improving Patient Outcomes with Behavioral Health Technology” at approximately 9:10am

Using a growing database of patient reactivity signatures can better predict milk-allergic patient outcomes compared to traditional methods, AllerGenis’ researchers report today in JACI

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in China and throughout the world, announces today that it has received National Medical Products Administration (“NMPA”) (formerly, the China FDA) approval of Melphalan Hydrochloride For Injection

KBI Biopharma, Inc. and Selexis SA announced today they have appointed four leading, internationally recognized scientists to their newly formed Joint Scientific Advisory Board (JSAB).

Nearly 80 percent of hospital pharmacists look forward to a greater role in healthcare and are well positioned to take on an expanded role, according to new research sponsored by AmerisourceBergen.